Clinical trial
Clinical Characteristics and Treatment Outcomes of Nasolacrimal Duct Obstruction Using Dacryoendoscopy
NCT05999058 is registered in ClinicalTrials.gov with Tianjin Eye Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Characteristics and Treatment Outcomes of Nasolacrimal Duct Obstruction Using Dacryoendoscopy
- Lead sponsor
- Tianjin Eye Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 1, 2019
- Completion date
- November 1, 2023
- Enrollment
- 522 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.